Related Experiment Video
Updated: Jun 11, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Alternative splicing and breast cancer
Martin Dutertre1, Stephan Vagner, Didier Auboeuf
1Institut National de la Santé et de la Recherche Médicale (INSERM) U590, Centre Léon Bérard, Lyon, France.
Abstract:
Alternative splicing is a key molecular event in the gene expression process. It allows for the synthesis of different products from the same gene, and consequently increases the complexity of the proteome encoded by a limited number of genes. Although alterations of alternative splicing are among the myriad of alterations present in tumor cells, increasing evidence indicates that cancer-associated splicing variants play an important role in tumor initiation and progression. Therefore, alternative splicing studies are opening new avenues of research in basic and translational molecular oncology.
Insights
Alternative splicing, a crucial gene expression process, generates protein diversity. Altered splicing in cancer cells significantly impacts tumor development, making it a key area for oncology research.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Alternative splicing is a fundamental mechanism in gene expression, enabling a single gene to produce multiple protein isoforms.
- This process significantly expands the proteome's complexity from a limited gene set.
- Aberrant alternative splicing is a common feature of cancer cells.
Purpose of the Study:
- To highlight the critical role of alternative splicing in cancer initiation and progression.
- To underscore the importance of studying cancer-associated splicing variants.
- To emphasize the potential of alternative splicing as a target in molecular oncology.
Main Methods:
- Review of current literature on alternative splicing in cancer.
- Analysis of the impact of splicing alterations on tumor biology.
- Identification of key cancer-associated splicing variants.
Main Results:
- Alternative splicing alterations are prevalent in tumors.
- Specific splicing variants are implicated in driving tumor initiation and progression.
- These variants represent potential biomarkers and therapeutic targets.
Conclusions:
- Alternative splicing is a significant driver of cancer development.
- Targeting cancer-associated splicing variants offers new therapeutic strategies.
- Further research in alternative splicing is crucial for advancing molecular oncology.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pre-mRNA Processing: RNA Splicing
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
